ghk cu bpc 157 tb 500 glow blend (GHK‑Cu / BPC‑157 / TB‑500) bpc-157 tb-500 ghk-cu blend Repair

intravenous TB-4 Phase 1 safety and pharmacokinetics, no dose-limiting or serious adverse events (Ann N Y Acad Sci 2010;1194:223229): NCT00743769 Centers for Disease Control and Prevention

These are not cherry-picked responders

Each COA is available as a downloadable PDF on the product page

Regenerative Medicine and Anti-Aging Applications Some healthcare practitioners have begun integrating BPC-157 and TB-500 into regenerative medicine and anti-aging treatment protocols, despite the limited clinical evidence supporting these uses

Manufacturing Origin: Inquire about the source of the raw materials and the manufacturing protocols